Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-013656-77Phase 3Active
Phase 3, double-blind trial of sinecatechins in congenital ichthyosis and lamellar ichthyosis (LI), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Responder rate based on improvement of clinical symptomatology. Started Aug 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-013656-77.